Previous close | 1,851.00 |
Open | 1,853.00 |
Bid | 1,814.41 x N/A |
Ask | 0.00 x N/A |
Day's range | 1,817.03 - 1,854.00 |
52-week range | 1,445.00 - 1,910.00 |
Volume | |
Avg. volume | 100 |
Market cap | 2.893T |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 19.56 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 93.04 (5.03%) |
Ex-dividend date | 21 Jun 2024 |
1y target est | N/A |
Oral nicotine pouches, an increasingly popular smokeless product, will likely undergo more regulatory and public scrutiny in the coming years.
(Bloomberg) -- Philip Morris International Inc. stopped online sales of its popular nicotine pouch brand Zyn in the US after receiving a subpoena in the District of Columbia related to flavored products that are banned there.Most Read from Bloomberg‘I Live in Hell’: Anti-Growth Fervor Grips US South After Pandemic BoomWhat to Know About the Deadly Flesh-Eating Bacteria Spreading in JapanNvidia Becomes World’s Most Valuable Company as AI Rally Steams AheadNvidia’s 591,078% Rally to Most Valuable
Philip Morris bought Swedish Match in a $16 billion deal in 2022 as the company looked to reduce its reliance on cigarettes amid stricter regulations, and a consumer shift towards alternatives to tobacco and traditional cigarettes. The company said that Swedish Match North America had received a subpoena from D.C.'s Attorney General requesting information about its compliance with D.C.'s 2022 ban on the sale of all flavored tobacco.